Segal Lloyd Mitchell 4
4 · Repare Therapeutics Inc. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Segal Lloyd Mitchell
DirectorPRESIDENT AND CEO
Transactions
- Award
Common Shares
2025-03-04+40,000→ 145,573 total - Award
Employee Stock Option (right to buy)
2025-03-04+237,000→ 237,000 totalExercise: $1.17Exp: 2035-03-03→ Common Shares (237,000 underlying)
Holdings
- 107,558(indirect: See footnote)
Common Shares
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of March 4, 2026, March 4, 2027 and March 4, 2028, subject to Reporting Person continuing to provide service through each such date.
- [F2]Includes 895 and 2,000 shares acquired on August 15, 2024 and February 15, 2025, respectively, under the Issuer's employee stock purchase plan.
- [F3]These securities are registered in the name of Arvala Inc. (f/k/a 3996953 Canada Inc., the "Company"). The Reporting Person is the sole stockholder of the Company.
- [F4]Twenty-five percent (25%) of the shares subject to the option shall vest on March 4, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.